Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
pioglitazone (actos) (1 trial)
sufonylurea (1 trial)
Cardiovascular Diseases (Phase 4)
Trials (1 total)
Trial APIs (2 total)